Login
Super Investors Eversept Partners, LP
EP

Eversept Partners, LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$1.86B
Positions
111
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (36 quarters reported)

$1.98B $174M
Q4 17 Q4 19 Q4 21 Q4 23 Q4 25 Q3 26

$174M in Q4 2017 → $1.86B now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
UT United Therapeutics Corp Del 9.5% Added 13% 324,729 $176M
Encompass Health Corp 7.1% Added 5.4% 1,082,316 $131M
Ensign Group Inc 6.7% Added 21% 726,186 $125M
AS Abivax Sa 5.9% Added 20% 1,100,655 $109M
IQ Invesco Qqq Tr Put 5.4% Added 37% 135,000 $99.9M
VT Vera Therapeutics Inc 4.1% Added 6.7% 2,361,996 $76.3M
Revvity Inc 3.7% Added 438% 449,790 $68.8M
Natera Inc 2.8% Trimmed 27% 128,126 $53M
Caretrust REIT Inc 2.7% Added 26% 1,352,628 $49.5M
OH Omega Healthcare Invs Inc 2.5% Added 109% 1,008,565 $46.7M
Syndax Pharmaceuticals Inc 2.5% Trimmed 13% 2,443,056 $45.9M
Guardant Health Inc 2.5% New 256,430 $45.7M
CT Celldex Therapeutics Inc New 2.0% Trimmed 34% 1,174,771 $38.1M
Waters Corp 1.8% New 75,422 $33.1M
Viking Therapeutics Inc 1.8% Added 67% 1,006,292 $32.8M
BS Brookdale Sr Living Inc 1.7% Trimmed 16% 2,867,143 $31.1M
Hca Healthcare Inc 1.6% Trimmed 30% 68,317 $29.2M
Vaxcyte Inc 1.6% Trimmed 19% 509,239 $29M
Travere Therapeutics Inc 1.4% Trimmed 43% 453,866 $26.7M
CH Community Health Sys Inc New 1.4% Added 16% 9,138,106 $26.1M
Grail Inc 1.4% New 182,154 $25.5M
Geron Corp 1.2% Trimmed 1.0% 18,527,499 $22.8M
CN Chemed Corp New 1.2% Trimmed 16% 43,905 $22.2M
Pennant Group Inc 1.1% Added 16% 536,051 $20.9M
LP Ltc Pptys Inc 1.1% Added 8.9% 457,995 $19.6M
Beta Bionics Inc 1.0% Trimmed 18% 1,023,872 $19.4M
Liquidia Corporation 1.0% Added 50% 641,986 $19.4M
Insmed Inc 1.0% Added 7.8% 160,810 $18.4M
Biomarin Pharmaceutical Inc 1.0% Added 22% 304,843 $18.3M
Bruker Corp 1.0% Added 53% 279,854 $18.1M
Tenet Healthcare Corp 1.0% Trimmed 38% 70,419 $18M
GH Goodrx Hldgs Inc 0.9% New 5,019,604 $16.5M
Cogent Biosciences Inc 0.8% Trimmed 2.1% 480,111 $15.4M
Roivant Sciences Ltd 0.8% New 419,138 $15.3M
SS State Str SPDR S&P 500 ETF T Put 0.8% New 20,000 $15.3M
Supernus Pharmaceuticals 0.8% New 347,862 $15M
Insulet Corp 0.7% Trimmed 32% 100,970 $13.2M
Repligen Corp 0.7% Added 350% 64,819 $12.5M
Relay Therapeutics Inc 0.7% Added 57% 681,711 $12.3M
Welltower Inc 0.6% Trimmed 47% 46,186 $10.6M
AP Arrowhead Pharmaceuticals In 0.5% New 156,219 $10.2M
Tarsus Pharmaceuticals Inc 0.5% Added 132% 129,279 $10.2M
Cytomx Therapeutics Inc. 0.5% Trimmed 0.4% 3,544,163 $9.64M
Summit Therapeutics Inc 0.5% New 526,646 $8.91M
Pacs Group Inc 0.5% Added 80% 211,736 $8.8M
Pharvaris N V 0.5% Trimmed 31% 265,118 $8.41M
Anaptysbio Inc 0.4% Added 121% 154,921 $7.79M
Molina Healthcare Inc 0.4% Trimmed 51% 39,385 $7.45M
UP Ultragenyx Pharmaceutical In 0.4% Added 214% 484,053 $7.28M
Sonida Senior Living Inc 0.4% Added 88% 193,155 $7.26M
Biocryst Pharmaceuticals Inc 0.4% Trimmed 54% 865,137 $7.21M
Unitedhealth Group Inc 0.4% Trimmed 63% 19,160 $7.03M
IT Ishares Tr Put 0.4% New 90,000 $7M
Biontech Se 0.3% New 61,667 $6.06M
Corvus Pharmaceuticals Inc 0.3% Trimmed 33% 503,017 $5.79M
NP Newamsterdam Pharma Company 0.3% Trimmed 19% 223,962 $5.45M
Ionis Pharmaceuticals Inc 0.3% Trimmed 82% 121,732 $5.44M
Vor Biopharma Inc 0.3% Added 79% 268,389 $5.12M
Structure Therapeutics Inc 0.3% Trimmed 21% 155,127 $4.85M
Mineralys Therapeutics Inc 0.3% Trimmed 39% 189,949 $4.77M

Showing top 60 of 111 positions.

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Revvity Inc Added +366,166 +$56M 3.7%
Guardant Health Inc New +256,430 +$45.7M 2.5%
Waters Corp New +75,422 +$33.1M 1.8%
IQ Invesco Qqq Tr Added +36,400 +$26.9M 5.4%
Grail Inc New +182,154 +$25.5M 1.4%
Gsk PLC Exited −481,833 −$25.3M —
OH Omega Healthcare Invs Inc Added +525,018 +$24.3M 2.5%
Ionis Pharmaceuticals Inc Trimmed −542,952 −$24.2M 0.3%
Eli Lilly & Co Exited −20,116 −$24.1M —
Ensign Group Inc Added +124,107 +$21.3M 6.7%

Showing the 10 largest of 137 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
IQ Invesco Qqq Tr Trimmed −140,100 −$103M 3.8%
Ensign Group Inc Added +587,318 +$94.1M 5.0%
Encompass Health Corp Added +832,815 +$84.2M 5.4%
SS State Str SPDR S&P 500 ETF T Exited −107,000 −$69.6M —
Gsk PLC Trimmed −1,303,342 −$68.3M 1.3%
Natera Inc Trimmed −208,906 −$56.7M 2.5%
Caretrust REIT Inc New +1,072,015 +$43.3M 2.2%
Vertex Pharmaceuticals Inc Exited −90,000 −$40.2M —
IT Ishares Tr Exited −428,800 −$37.2M —
HP Healthpeak Properties Inc Exited −1,981,070 −$32.5M —

Showing the 10 largest of 145 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Gsk PLC Trimmed −894,546 −$49.4M 5.2%
BS Brookdale Sr Living Inc Added +3,193,626 +$43.7M 2.6%
Danaher Corporation Exited −186,262 −$42.6M —
SS State Str SPDR S&P 500 ETF T Added +62,100 +$40.4M 3.7%
Vertex Pharmaceuticals Inc New +90,000 +$40.2M 2.1%
VT Vera Therapeutics Inc Trimmed −899,018 −$36.2M 4.6%
Welltower Inc New +180,953 +$35.8M 1.9%
HP Healthpeak Properties Inc New +1,981,070 +$32.5M 1.7%
AS Abivax Sa Added +276,589 +$30.8M 5.5%
OH Omega Healthcare Invs Inc New +585,680 +$25.7M 1.4%

Showing the 10 largest of 148 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
Natera Inc Trimmed −185,151 −$42.4M 3.9%
Zimvie Inc Exited −2,079,380 −$39.4M —
AS Abivax Sa Added +231,335 +$31.2M 4.5%
SS SPDR S&P 500 ETF Tr New +44,900 +$30.6M 1.5%
Gsk PLC Added +559,275 +$27.4M 6.6%
Avantor Inc Added +2,252,202 +$25.8M 1.8%
Exact Sciences Corp New +241,678 +$24.5M 1.2%
Revvity Inc Trimmed −231,534 −$22.4M 0.8%
TP Teva Pharmaceutical Inds Ltd Trimmed −703,476 −$22M 1.0%
Cidara Therapeutics Inc New +98,721 +$21.8M 1.1%

Showing the 10 largest of 122 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
UT United Therapeutics Corp Del Added +193,854 +$81.3M 7.3%
UN Uniqure Nv New +877,373 +$51.2M 3.5%
Natera Inc Trimmed −276,731 −$44.5M 5.8%
AS Abivax Sa New +426,499 +$36.2M 2.5%
IQ Invesco Qqq Tr Added +57,800 +$34.7M 9.5%
IM Inspire Med Sys Inc Exited −164,473 −$21.3M —
IH Iqvia Hldgs Inc Exited −97,604 −$15.4M —
Protagonist Therapeutics Inc Exited −277,316 −$15.3M —
Danaher Corporation Added +75,824 +$15M 1.4%
Insulet Corp New +45,604 +$14.1M 1.0%

Showing the 10 largest of 94 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
SS SPDR S&P 500 ETF Tr Exited −76,900 −$43M —
IQ Invesco Qqq Tr Added +48,600 +$26.8M 8.7%
Vaxcyte Inc Added +741,444 +$24.1M 3.9%
Healthequity Inc Trimmed −196,108 −$20.5M 1.5%
Revvity Inc Added +211,243 +$20.4M 4.5%
Hca Healthcare Inc Trimmed −52,519 −$20.1M 3.5%
Unitedhealth Group Inc New +60,736 +$18.9M 1.7%
Illumina Inc New +198,584 +$18.9M 1.7%
Avantor Inc Added +1,403,341 +$18.9M 1.9%
Neurocrine Biosciences Inc Exited −167,243 −$18.5M —

Showing the 10 largest of 71 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
IQ Invesco Qqq Tr Trimmed −119,500 −$56M 5.9%
Syndax Pharmaceuticals Inc Added +3,868,870 +$47.5M 5.3%
Gsk PLC Trimmed −1,038,522 −$40.2M 10.3%
SS SPDR S&P 500 ETF Tr Added +47,100 +$26.3M 4.4%
Neurocrine Biosciences Inc New +167,243 +$18.5M 1.9%
IM Inspire Med Sys Inc Trimmed −107,877 −$17.2M 3.0%
Vaxcyte Inc Added +429,482 +$16.2M 2.1%
Viatris Inc Exited −1,272,102 −$15.8M —
IT Ishares Tr Exited −179,400 −$15.7M —
Glaukos Corp New +158,957 +$15.6M 1.6%

Showing the 10 largest of 76 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Insmed Inc Exited −1,089,404 −$79.5M —
Syndax Pharmaceuticals Inc Trimmed −3,761,913 −$49.7M 0.4%
UT United Therapeutics Corp Del Trimmed −87,246 −$30.8M 1.4%
Bio-techne Corp Trimmed −364,263 −$26.2M 1.9%
TP Teva Pharmaceutical Inds Ltd Trimmed −992,513 −$21.9M 4.4%
VT Vera Therapeutics Inc Trimmed −450,142 −$19M 6.0%
CH Community Health Sys Inc New Trimmed −5,949,455 −$17.8M 0.8%
SS SPDR S&P 500 ETF Tr Trimmed −30,200 −$17.7M 1.6%
Repligen Corp Trimmed −109,527 −$15.8M 0.7%
IT Ishares Tr New +179,400 +$15.7M 1.4%

Showing the 10 largest of 77 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support